- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.05 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.2: 4 residues within 4Å:- Chain A: T.190, L.227, N.230, Y.234
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:L.227
- Hydrogen bonds: A:N.230
- Water bridges: A:N.230, A:N.230
NAG.3: 1 residues within 4Å:- Chain A: N.211
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.211
NAG.4: 2 residues within 4Å:- Chain A: N.201, E.202
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:E.202, A:E.202
NAG.5: 5 residues within 4Å:- Chain A: G.237, K.238, R.239, N.241, V.283
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:K.238, A:K.238
NAG.11: 3 residues within 4Å:- Chain B: N.117, K.121
- Chain D: T.115
2 PLIP interactions:1 interactions with chain D, 1 interactions with chain B- Hydrophobic interactions: D:T.115
- Hydrogen bonds: B:K.121
NAG.14: 4 residues within 4Å:- Chain C: T.190, L.227, N.230, Y.234
4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:L.227
- Hydrogen bonds: C:N.230
- Water bridges: C:N.230, C:N.230
NAG.15: 1 residues within 4Å:- Chain C: N.211
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.211
NAG.16: 2 residues within 4Å:- Chain C: N.201, E.202
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:E.202, C:E.202
NAG.17: 5 residues within 4Å:- Chain C: G.237, K.238, R.239, N.241, V.283
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:K.238, C:K.238
NAG.23: 3 residues within 4Å:- Chain D: N.117, K.121
- Chain F: T.115
2 PLIP interactions:1 interactions with chain D, 1 interactions with chain F- Hydrogen bonds: D:K.121
- Hydrophobic interactions: F:T.115
NAG.26: 4 residues within 4Å:- Chain E: T.190, L.227, N.230, Y.234
4 PLIP interactions:4 interactions with chain E- Hydrophobic interactions: E:L.227
- Hydrogen bonds: E:N.230
- Water bridges: E:N.230, E:N.230
NAG.27: 1 residues within 4Å:- Chain E: N.211
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.211
NAG.28: 2 residues within 4Å:- Chain E: N.201, E.202
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:E.202, E:E.202
NAG.29: 5 residues within 4Å:- Chain E: G.237, K.238, R.239, N.241, V.283
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:K.238, E:K.238
NAG.35: 3 residues within 4Å:- Chain B: T.115
- Chain F: N.117, K.121
2 PLIP interactions:1 interactions with chain B, 1 interactions with chain F- Hydrophobic interactions: B:T.115
- Hydrogen bonds: F:K.121
- 9 x GOL: GLYCEROL(Non-functional Binders)
GOL.6: 4 residues within 4Å:- Chain A: W.77, E.79, F.263
- Chain B: H.15
5 PLIP interactions:3 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:E.79, A:E.79
- Water bridges: A:E.76, B:N.11, B:H.15
GOL.7: 5 residues within 4Å:- Chain A: E.93, C.94, L.95, P.96, D.123
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:L.95, A:D.123, A:R.145
- Water bridges: A:A.97
GOL.12: 6 residues within 4Å:- Chain B: N.62, E.63, T.65, Q.66
- Chain F: W.30
- Ligands: NAG-NAG-BMA-MAN-MAN.1
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:N.62, B:E.63, B:T.65, B:Q.66
GOL.18: 4 residues within 4Å:- Chain C: W.77, E.79, F.263
- Chain D: H.15
5 PLIP interactions:2 interactions with chain D, 3 interactions with chain C- Water bridges: D:N.11, D:H.15, C:E.76
- Hydrogen bonds: C:E.79, C:E.79
GOL.19: 5 residues within 4Å:- Chain C: E.93, C.94, L.95, P.96, D.123
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:L.95, C:D.123, C:R.145
- Water bridges: C:A.97
GOL.24: 6 residues within 4Å:- Chain B: W.30
- Chain D: N.62, E.63, T.65, Q.66
- Ligands: NAG-NAG-BMA-MAN-MAN.13
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:N.62, D:E.63, D:T.65, D:Q.66
GOL.30: 4 residues within 4Å:- Chain E: W.77, E.79, F.263
- Chain F: H.15
5 PLIP interactions:2 interactions with chain F, 3 interactions with chain E- Water bridges: F:N.11, F:H.15, E:E.76
- Hydrogen bonds: E:E.79, E:E.79
GOL.31: 5 residues within 4Å:- Chain E: E.93, C.94, L.95, P.96, D.123
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:L.95, E:D.123, E:R.145
- Water bridges: E:A.97
GOL.36: 6 residues within 4Å:- Chain D: W.30
- Chain F: N.62, E.63, T.65, Q.66
- Ligands: NAG-NAG-BMA-MAN-MAN.25
4 PLIP interactions:4 interactions with chain F- Hydrogen bonds: F:N.62, F:E.63, F:T.65, F:Q.66
- 6 x GON: 1-[2-[3-oxidanyl-4-(4-phenyl-1~{H}-pyrazol-5-yl)phenoxy]ethyl]piperidine-4-carboxamide(Non-covalent)
GON.8: 7 residues within 4Å:- Chain A: I.11, L.159, P.160, A.162
- Chain B: M.47, L.53
- Ligands: GON.9
4 PLIP interactions:2 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:L.53, B:L.53, A:L.159, A:P.160
GON.9: 14 residues within 4Å:- Chain A: N.34, R.37, V.39, E.73, A.74
- Chain B: L.14, Y.16, T.18, T.19, D.21, M.47, L.57
- Chain D: R.86
- Ligands: GON.8
16 PLIP interactions:2 interactions with chain D, 6 interactions with chain A, 8 interactions with chain B- Hydrogen bonds: D:R.86, D:R.86, B:Y.16
- Hydrophobic interactions: A:R.37, A:V.39, B:L.14, B:Y.16, B:Y.16, B:T.18, B:L.57
- Water bridges: A:T.33, A:E.73
- Salt bridges: A:E.73, B:D.21
- pi-Cation interactions: A:R.37
- pi-Stacking: B:Y.16
GON.20: 7 residues within 4Å:- Chain C: I.11, L.159, P.160, A.162
- Chain D: M.47, L.53
- Ligands: GON.21
4 PLIP interactions:2 interactions with chain C, 2 interactions with chain D- Hydrophobic interactions: C:L.159, C:P.160, D:L.53, D:L.53
GON.21: 14 residues within 4Å:- Chain C: N.34, R.37, V.39, E.73, A.74
- Chain D: L.14, Y.16, T.18, T.19, D.21, M.47, L.57
- Chain F: R.86
- Ligands: GON.20
16 PLIP interactions:6 interactions with chain C, 2 interactions with chain F, 8 interactions with chain D- Hydrophobic interactions: C:R.37, C:V.39, D:L.14, D:Y.16, D:Y.16, D:T.18, D:L.57
- Water bridges: C:T.33, C:E.73
- Salt bridges: C:E.73, D:D.21
- pi-Cation interactions: C:R.37
- Hydrogen bonds: F:R.86, F:R.86, D:Y.16
- pi-Stacking: D:Y.16
GON.32: 7 residues within 4Å:- Chain E: I.11, L.159, P.160, A.162
- Chain F: M.47, L.53
- Ligands: GON.33
4 PLIP interactions:2 interactions with chain E, 2 interactions with chain F- Hydrophobic interactions: E:L.159, E:P.160, F:L.53, F:L.53
GON.33: 14 residues within 4Å:- Chain B: R.86
- Chain E: N.34, R.37, V.39, E.73, A.74
- Chain F: L.14, Y.16, T.18, T.19, D.21, M.47, L.57
- Ligands: GON.32
16 PLIP interactions:6 interactions with chain E, 8 interactions with chain F, 2 interactions with chain B- Hydrophobic interactions: E:R.37, E:V.39, F:L.14, F:Y.16, F:Y.16, F:T.18, F:L.57
- Water bridges: E:T.33, E:E.73
- Salt bridges: E:E.73, F:D.21
- pi-Cation interactions: E:R.37
- Hydrogen bonds: F:Y.16, B:R.86, B:R.86
- pi-Stacking: F:Y.16
- 3 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
DMS.10: 6 residues within 4Å:- Chain A: V.10, I.11, H.12, D.28, K.29, P.160
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:K.29
- Salt bridges: A:D.28
DMS.22: 6 residues within 4Å:- Chain C: V.10, I.11, H.12, D.28, K.29, P.160
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:K.29
- Salt bridges: C:D.28
DMS.34: 6 residues within 4Å:- Chain E: V.10, I.11, H.12, D.28, K.29, P.160
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:K.29
- Salt bridges: E:D.28
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Shaikh, F. et al., Structure-Based in Silico Screening Identifies a Potent Ebolavirus Inhibitor from a Traditional Chinese Medicine Library. J.Med.Chem. (2019)
- Release Date
- 2019-02-27
- Peptides
- Envelope glycoprotein,GP1,Envelope glycoprotein: ACE
Envelope glycoprotein: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.05 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 9 x GOL: GLYCEROL(Non-functional Binders)
- 6 x GON: 1-[2-[3-oxidanyl-4-(4-phenyl-1~{H}-pyrazol-5-yl)phenoxy]ethyl]piperidine-4-carboxamide(Non-covalent)
- 3 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Shaikh, F. et al., Structure-Based in Silico Screening Identifies a Potent Ebolavirus Inhibitor from a Traditional Chinese Medicine Library. J.Med.Chem. (2019)
- Release Date
- 2019-02-27
- Peptides
- Envelope glycoprotein,GP1,Envelope glycoprotein: ACE
Envelope glycoprotein: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AE
AB
BD
BF
B